Want to see HK:1477 full AI Analyst Report?
Ocumension Therapeutics (1477) Revenue
Ocumension Therapeutics Revenue
Ocumension Therapeutics had a revenue of 423.71M in the quarter ending Jun 30, 2026, with -16.97%. This bring the company's revenue in the last twelve months to 934.03M, Increased 16.12%. In the fiscal year ending Dec 31, 2025, Ocumension Therapeutics had annual revenue of 804.35M with 92.75% growth.
- Revenue (ttm)
- 934.03M
- Revenue Growth
- 77.55%
- P/S Ratio
- 4.86
- Revenue/Employee
- HKD 1,322,947
- Employees
- 608
- Market Cap
- HKD 3.91B
Revenue Chart
Ocumension Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 804.35M | 387.05M | 92.75% |
| Dec 31, 2024 | 417.31M | 170.94M | 69.38% |
| Dec 31, 2023 | 246.37M | 87.41M | 54.99% |
| Dec 31, 2022 | 158.96M | 102.81M | 183.11% |
| Dec 31, 2021 | 56.15M | 43.05M | 328.73% |
| Dec 31, 2020 | 13.10M | 12.91M | 6792.63% |
| Dec 31, 2019 | 190.00K | 190.00K | ― |
| Dec 31, 2018 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.